Seeking Alpha

Henry Schein (HSIC -7.4%) beat Q3 estimates, but earnings climbed less-than-expected as the...

Henry Schein (HSIC -7.4%) beat Q3 estimates, but earnings climbed less-than-expected as the vaccine maker suffered from lower sales of its flu shots and margin pressure due to higher costs. The company also issues cautious guidance for FY12, citing foreign currency concerns.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|